The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth.

Autor: Nelson, David B., Herrera, Christina L., McIntire, Donald D., Cunningham, F. Gary
Předmět:
Zdroj: American Journal of Obstetrics & Gynecology; Jan2024, Vol. 230 Issue 1, p1-9, 9p
Databáze: Supplemental Index
Externí odkaz: